Insights

In this 12-minute podcast, Vrinda Bhardwaj, MD, from Children's Hospital Los Angeles, reviews the use of elemental and elimination diets for treatment of eosinophilic gastrointestinal diseases in children.

He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.

In this video, Alan Bonder, MD, talks about how to start the conversation about using telemedicine with patients, how to have a telemedicine visit with a patient, and how to keep everyone at home for a quicker return to normal.

He discusses his session titled “The Microbiome and Fatty Liver Disease,” which he presented at Harvard’s Nonalcoholic Fatty Liver Disease (NAFLD): Mechanisms and Novel Therapeutics symposium.

He talks about the treatment options that are available for treating nonalcoholic fatty liver disease via metabolic pathways. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.

He talks about how and why metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD.

He discusses how gastroenterologists can resume semi-elective and elective endoscopies by following key guidelines to protect patients and staff against COVID-19.

He talks about his latest research paper in which his team used machine learning to develop a risk-stratification model to predict which patients would experience upper gastrointestinal bleeding and then compared the model’s performance with...

The relationship between climate change and human health has not been thoroughly explored. Desmond Leddin, MB, MSc, has taken an interest in studying this relationship. In this Q&A, he answers our questions about his latest article on the...